-
Navigation
- Company
- Products
- Innovation
- Patients
- Grünenthal's Press Centre
- Partnering
- Jobs & Career
Grünenthal press release 2012
New PAIN Compendium provides up-to-date information on pain and its therapy to support healthcare practitioners’ daily work
CHANGE PAIN® presents new international textbook on pain management at EULAR Congress
Berlin, 6 June, 2012 – The CHANGE PAIN® initiative1 today presents the PAIN Compendium – a new tool being part of the PAIN EDUCATION program – on the occasion of the Annual European Congress of the European League against Rheumatism (EULAR), taking place in Berlin from 6 to 9 June. The PAIN Compendium is a comprehensive international textbook about pain and its therapy, intended for healthcare professionals regularly facing patients with pain in their daily practice, as well as healthcare professionals and students with an interest in pain. With the PAIN Compendium, healthcare practitioners receive a comprehensive insight into pain and its management supporting them in understanding their pain patients’ needs and developing individual treatment plans.
Patients with severe chronic pain need better treatment so that the high burden of pain for society can be minimized.[2] The PAIN Compendium is a valuable source of information for healthcare professionals and students interested in pain as well as physicians facing patients with pain in their daily practice. The content provided within the textbook or the DVD enables state-of-the-art pain management by giving the reader the opportunity to learn more about the basics of pain therapy as well as the current challenges and latest research findings. Animations and videos are used to supplement information about the underlying mechanisms of pain, pain assessment and the patient perspective.
PAIN Compendium combines basic information and special cases
The PAIN Compendium begins with the basics of pain management and moves on to explain pain physiology, subsequent therapeutic measures and interdisciplinary approaches. In the chapter treatment modalities, readers find insights into therapies including the novel therapeutic class MOR-NRI. The clinical states section introduces different indications such as back pain, neuropathic pain or rheumatological pain, providing basic information on epidemiology, symptoms and current guidelines but also giving details of related diseases (e.g. postherpetic neuralgia) and their evaluation. Special cases focus on pain in the elderly or pain in children, exploring areas that are not necessarily well understood among healthcare practitioners.
Adding to the PAIN EDUCATION program
The new textbook is part of the interactive PAIN EDUCATION program, developed according to the recommendations of the international CHANGE PAIN® advisory board, and aiming to educate healthcare professionals about the management of chronic pain. So far, the program includes five electronic UEMS certified Continuing Medical Education (eCME) modules, with two further modules currently in development.
With 27 chapters and more than 400 pictures, the PAIN Compendium provides thorough insights on the basics of pain management, treatment modalities, different clinical states and special cases for interested healthcare professionals. The textbook was developed by international experts in the area of pain management from across Europe and edited by Dr Reinhard Sittl. Healthcare practitioners can access the PAIN Compendium free of charge on the CHANGE PAIN® website (www.change-pain.com) but are asked to register in order to ensure the user’s medical background. The PAIN Compendium will be available for the first time at the Grünenthal booth during the EULAR. Currently, the textbook is available in English and German, but more translations are under development.
About CHANGE PAIN®
CHANGE PAIN® aims to enhance the understanding of the needs of patients with severe chronic pain and to develop solutions to improve chronic pain management. Initiated by the German pain expert Grünenthal and endorsed by the European Federation of the IASP® Chapters (EFIC®), the initiative involves pain experts from across Europe. The international Advisory Board is chaired by Professor Hans-Georg Kress, Chair of the Department of Special Anesthesia and Pain Therapy, Medical University/AKH Vienna, Austria and President of EFIC® , and Dr Gerhard H. H. Müller-Schwefe, MD, Head of Centre for Interdisciplinary Pain Therapy & Palliative Care, Goeppingen, Germany and President of the German Pain Association (DGS). Key objectives of CHANGE PAIN® are to generate a better understanding of physicians’ and patients’ perspectives, publish the results of research projects and communicate findings in scientific publications, as well as to increase knowledge of pain physiology to facilitate individual treatment decisions.
More information: www.change-pain.com
About EFIC®
The European Federation of IASP® Chapters (EFIC®) is a multidisciplinary professional organisation in the field of pain research and medicine, consisting of the 36 European chapters of the International Association of the Study of Pain (IASP®), which are the IASP® accredited official pain societies in each country. Established in 1993, EFIC’s constituent chapters represent pain societies from 36 European countries and close to 20,000 scientists, physicians, nurses, physiotherapists, psychologists and other healthcare professionals across Europe, who are involved in pain management and pain research.
More about EFIC: www.efic.org
About Grünenthal
The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain, its objective is to become the most patient-centric company and thus to be a leader in therapy innovation. Grünenthal is one of the last five research-oriented pharmaceutical corporations with headquarters in Germany which sustainably invests in research and development. These investments amounted to about 25 percent of revenues in 2011. Grünenthal’s research and development strategy concentrates on select fields of therapy and state-of-the-art technologies. We focus on the intensive search for new ways to treat pain better, more effectively and with fewer side-effects than before. Altogether, the Grünenthal Group has affiliates in 26 countries worldwide. Grünenthal products are sold in more than 155 countries and today approx. 4,200 employees are working for the Grünenthal Group worldwide. In 2011, Grünenthal achieved revenues of €947 mn.
1 CHANGE PAIN® is a pan-European initiative by the German pain expert Grünenthal that aims to enhance the understanding of the needs of patients with severe chronic pain and to develop solutions to improve pain management.
[1] References Breivik H, Cherny N, Collet B, de Conno F, Filbet M, Foubert AJ, et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol. 2009; 20(8):1420-1433.
[2] Varrassi et al. Pharmacological treatment of chronic pain - the need for CHANGE. Curr Med Res Opin 2010; 26(5):1231-12345.
- 2012_06_05 Press Release PAIN Compendium (pdf, 335.8 KB)
Grünenthal Group
